Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
U.S. Disrupts China-Linked Hacking Campaign Targeting Government Agencies 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
Add as a preferred source on Google
Blindness is an unfortunate impairment that affects millions around the world, but advanced medical technology offers hope. 10 patients who suffer from a form of blindness called Retinitis pigmentosa will be given the chance to have their sight restored via the installation of bionic eyes. This is the next frontier of medical science where science fiction finally becomes scientific fact.
The project will be conducted using the Argus® II Retinal Prosthesis System, which is a tandem of computer relay and camera sensors installed on a pair of glasses. As the system’s website explains, it basically works by having two electronic setups communicate with each other in order to restore vision for the patients.
“A miniature video camera housed in the patient's glasses captures a scene,” the website’s bionic eye section reads. “The video is sent to a small patient-worn computer (i.e., the video processing unit – VPU) where it is processed and transformed into instructions that are sent back to the glasses via a cable. These instructions are transmitted wirelessly to an antenna in the retinal implant. The signals are then sent to the electrode array, which emits small pulses of electricity. These pulses bypass the damaged photoreceptors and stimulate the retina's remaining cells, which transmit the visual information along the optic nerve to the brain, creating the perception of patterns of light.”
Before the Argus II program, patients who suffered from Retinitis pigmentosa had no hope for treatment, which effectively doomed them to a state of blindness forever, Futurism reports. Treatment will be delivered in groups, with five of the patients going to Manchester Royal Eye Hospital and the other five going to Moorfields Eye Hospital.
Their treatment will start in 2017 and if proven successful, the treatment could be made available to the estimated 16,000 patients who suffer from the impairment in the UK alone. Global delivery will likely take some time as well.
